Background Antiviral prophylaxis is commonly used in recipients of solid-organ transplants
with the aim of preventing the clinical syndrome associated with cytomegalovirus infection …

Cytomegalovirus (CMV) is a common viral pathogen that influences the outcome of liver
transplantation. In addition to the direct effects of CMV syndrome and tissue-invasive …

Background: Cytomegalovirus (CMV), the most common opportunistic viral infection in solid
organ transplant recipients, is associated with substantial morbidity and mortality. Purpose …

Background. A randomized, double-blind study was conducted to evaluate the
pharmacokinetics of ganciclovir following oral administration of ganciclovir or valganciclovir …

Background. Cytomegalovirus (CMV) causes significant morbidity and mortality in transplant
recipients, but there is no consensus regarding the most appropriate prevention method …

Background Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid
organ transplant recipients. Pre‐emptive treatment of patients with CMV viraemia using …

Cytomegalovirus (CMV) infection remains a major complication of solid organ
transplantation. Because of management of CMV is variable among transplant centers, in …

Transplant recipients receiving immunosuppressive therapy are at increased risk of active
cytomegalovirus (CMV) infection and disease. Without appropriate prophylaxis, as many as …

Diarrhea is common after liver transplantation (LT). The true incidence of diarrhea in liver
transplant recipients is unknown but possibly ranges from 10% to 43% based on a few …

Despite broad variability in study populations, methodologies for CMV detection, and
analytic methods used, multiple studies have documented frequent CMV infection in non …